Endothelial cell, but not neutrophil, programmed cell death receptor-ligand 1 loss has a morbid impact on experimental murine shock/sepsis-induced lung injury. [PDF]
Front ImmunolTindal EW +7 more
europepmc +1 more source
Intrapatient variation in PD-L1 expression and tumor mutational burden and implications for outcomes to immune checkpoint inhibitor therapy in patients with non-small-cell lung cancer. [PDF]
J Immunother CancerLi G +7 more
europepmc +1 more source
Spatial Transcriptome Analysis of B7-H4 in Head and Neck Squamous Cell Carcinoma: A Novel Therapeutic Target for Anti-Immune Checkpoint Inhibitors. [PDF]
Head Neck PatholNoda Y, Yagi M, Tsuta K.
europepmc +1 more source
Differential Expression of Apoptosis-Stimulating Proteins of p53 (ASPPs) Between Langerhans Cell Histiocytosis and Langerhans Cell Sarcoma. [PDF]
Diagnostics (Basel)Wang C +7 more
europepmc +1 more source
Limited Clinical Benefit of Immune Checkpoint Inhibition in Ovarian Cancer with Opportunities in Selected Subtypes. [PDF]
Int J Mol SciRatka Z, Gamian A, Woźniak M.
europepmc +1 more source
NKAIN1 expression relates to the immune evasion and prognosis of gastric cancer. [PDF]
Sci RepZhou L +5 more
europepmc +1 more source
Case Report: A rare case of primary undifferentiated pleomorphic sarcoma of the renal pelvis with high PD-L1 expression and a misleading positive urine FISH. [PDF]
Front ImmunolLi J, Wang X, Zhen J, Qi M.
europepmc +1 more source
Identification of c-Met on Tumor Cells as a Novel Receptor for B7-H3 Entails Implications for Cancer Cell Stemness and Targeted Therapy. [PDF]
MedComm (2020)Cao L +16 more
europepmc +1 more source
Research progress of B7-H3 in malignant tumors. [PDF]
Front ImmunolZhao S, Zhang H, Shang G.
europepmc +1 more source